Clinical Research Unit

Los Angeles, California 90095

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, MELANOMA, NSCLC, OTHER SOLID TUMORS, OVCA, Part 1, Part 1 and 2, SARCOMA, SCCHN, UROTHELIAL CARCINOMA

Studies at this site

• A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early